Supernus Pharmaceuticals CEO Jack Khattar's 2020 pay slips 18% to $6.7M
Supernus Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 30, 2021
Supernus Pharmaceuticals reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, six executives at Supernus Pharmaceuticals received on average a compensation package of $2.1M, a 20% decrease compared to previous year.
Average pay of disclosed executives at Supernus Pharmaceuticals
Jack A. Khattar, Chief Executive Officer, received $6.7M in total, which decreased by 18% compared to 2019. 59% of Khattar's compensation, or $4M, was in option awards. Khattar also received $816K in non-equity incentive plan, $836K in salary, $1M in stock awards, as well as $28K in other compensation.
For fiscal year 2020, the median employee pay was $148,804 at Supernus Pharmaceuticals. Therefore, the ratio of Jack A. Khattar's pay to the median employee pay was 45 to one.
James P. Kelly, Chief Financial Officer, received a compensation package of $1.8M. 91% of the compensation package, or $1.6M, was in option awards.
Stefan K.F. Schwabe, Chief Medical Officer, earned $1.2M in 2020, a 19% decrease compared to previous year.
Gregory S. Patrick, Chief Financial Officer, received $1.2M in 2020, which decreases by 20% compared to 2019.
Padmanabh P. Bhatt, Chief Scientific Officer, earned $1.1M in 2020, a 18% decrease compared to previous year.
Tami Martin, R.N., Senior Vice President, Regulatory Affairs, received $805K in 2020, which decreases by 8% compared to 2019.
Related executives
Jack Khattar
Supernus Pharmaceuticals
Chief Executive Officer
James Kelly
Supernus Pharmaceuticals
Chief Financial Officer
Stefan Schwabe
Supernus Pharmaceuticals
Chief Medical Officer
Padmanabh Bhatt
Supernus Pharmaceuticals
Chief Scientific Officer
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
Tami RN
Supernus Pharmaceuticals
Senior Vice President, Regulatory Affairs
You may also like
Source: SEC filing on April 30, 2021.